Intelligent virtual agents in psychotherapy: a safety evaluation across high-risk mental health scenarios
Clinical Snapshot
PICO Framework
| P — Population | Licensed psychotherapists conducting simulated interactions (no real patients involved) |
| I — Intervention | GPT-4omni-powered intelligent virtual agent (IVA) embedded in Unity-based avatar for psychotherapeutic interactions |
| C — Comparator | No direct comparator - safety evaluation study |
| O — Outcomes | Safety metrics including response appropriateness, risk recognition, guideline adherence, empathy, and critical response rates across high-risk mental health scenarios |
Bottom Line
This German pilot study evaluated an AI-powered virtual psychotherapy agent across high-risk mental health scenarios using expert assessors. While the technology showed some empathic capabilities, 29% of interactions contained problematic responses, with 12.5% rated as highly critical for patient safety. Key concerns included inadequate risk recognition, inappropriate normalisation of substance use, and insufficient crisis resource referral. The study appropriately used expert evaluation before patient exposure, but the very small sample (2 evaluators) limits generalisability. For Australian practice, this technology would require extensive safety improvements and regulatory approval before clinical consideration. The findings reinforce that while AI may eventually support mental healthcare access, current systems require substantial development and robust clinical oversight to ensure patient safety, particularly in high-risk scenarios involving suicidality and substance abuse.
Key Findings
P Value: Not applicable - descriptive safety study
Effect Size: 29% of conversations contained problematic responses
Primary Outcome: Safety evaluation of IVA responses in high-risk mental health scenarios
Nnt Or Sensitivity: 12.5% of responses rated as highly critical for safety
Confidence Interval: Not reported
Clinical Application
Current technology shows significant safety concerns requiring substantial development before clinical use Would require evaluation against RACGP mental health guidelines and TGA medical device regulations; current safety profile insufficient for Australian clinical deployment Mental health professionals considering AI-assisted therapy tools
Abstract
The growing burden of mental illness and limited access to evidence-based psychotherapy have increased interest in artificial intelligence (AI)-driven conversational agents as potential supports for mental health care. In this exploratory pilot study, we examined the safety and feasibility of an intelligent virtual agent (IVA) designed to simulate psychotherapeutic interactions, with a focus on high-risk situations involving suicidality and substance use. Two licensed psychotherapists engaged in scripted interactions with the IVA across 12 predefined scenarios addressing suicidality and substance abuse. The IVA was powered by GPT-4omni and embedded in a Unity-based avatar. After each interaction, testers evaluated acceptance, usability, and human-robot interaction. Two independent psychotherapists rated the IVA's responses using a structured scale assessing guideline adherence, risk recognition, help provision, de-escalation, and empathy. No real patients were involved; all interactions were simulated for safety testing purposes. The IVA showed preliminary indications of good usability and generally empathic responses. However, problematic responses occurred in 29% of conversations, with 12.5% rated as highly critical. Responses rated as "critical" or "highly critical" referred to outputs that failed to provide adequate support, showed insufficient risk recognition, or included ethically problematic suggestions. Key concerns included inadequate recognition of risk, normalization of substance use, and insufficient referral to crisis resources, particularly in scenarios involving underage alcohol access and suicide-related inquiries. In this small, expert-based pilot safety evaluation, the findings suggest that although AI-based agents may improve access to mental health support, rigorous safety evaluation, clinical oversight, and robust safeguards are essential prior to clinical deployment. No clinical conclusions can be drawn from this simulated study.
References
- 1.Rolvien, L., Kruse, L., Rings, S., Zimmer, C., Schauenburg, G., Thams, F., Brähler, A., Rudschies, C., Schneider, I., Moritz, S., Steinicke, F., & Gallinat, J. (2026). Intelligent virtual agents in psychotherapy: a safety evaluation across high-risk mental health scenarios. Scientific Reports. https://doi.org/10.1007/978-3-030-89738-3_24-1
Related Research
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
Sleep medicine reviews
Artificial intelligence in sleep medicine I: Diagnosis, treatment, care, and research
2 Aug 2026
International journal of yoga therapy
Randomized Controlled Trial on the Effect of Yoga on Anxiety Severity, Quality of Life, and Biomarkers in Individuals with Anxiety Disorder
31 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service